Postprandial dyslipidemia: A risk factor for coronary heart disease

Annals of Nutrition and Metabolism

Volumn 42, Issue 1, 1998, Pages 1-11

  Dallongeville, Jean ^a   Fruchart, Jean Charles ^b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN E; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AGING; ARTICLE; ATHEROGENESIS; BODY WEIGHT; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL RESEARCH; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; DYSLIPIDEMIA; EXERCISE; GENETIC ASSOCIATION; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INTESTINE MOTILITY; ISCHEMIC HEART DISEASE; LIPID DIET; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA CLEARANCE; POSTPRANDIAL STATE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

CORONARY DISEASE; HUMANS; HYPERLIPIDEMIAS; POSTPRANDIAL PERIOD; RISK FACTORS;

EID: 0031930192     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000012712     Document Type: Article

References (55)

1. Miesenböck G, Patsch JR: Postprandial hyperlipidemia: The search for the atherogenic lipoprotein. Curr Opin Lipidol 1992;3:196-201.
2. Bergeron N, Havel RJ: Assessment of postprandial lipemia: Nutritional influences. Curr Opin Lipidol 1997; 8:43-52.
3. Föger B, Patsch JR: Strategies and methods for the assessment of disturbed postprandial lipid metabolism. Curr Opin Lipidol 1993;4: 428-433.
4. Cohn JS: Postprandial lipid metabolism. Curr Opin Lipidol 1994;5: 185-190.
5. Karpe F, Hamsten A: Postprandial lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 1995;6: 123-129.
6. Demacker PNM: Diets and postprandial lipoproteins. Curr Opin Lipidol 1995;6:43-47.
7. Havel RJ: Postprandial hyperlipidemia and remnant lipoproteins. Curr Opin Lipidol 1994;5:102-109.
8. Mahley RW, Hussain MM: Chylomicron and chylomicron remnant catabolism. Curr Opin Lipidol 1991;2:170-176.
9. Zilversmit DB: Atherogenesis: A postprandial phenomenon. Circulation 1979;60:473-485.
10. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ: Plasma apolipoprotein changes in the triglyceride-rich lipoprotein fraction of human subjects fed a fat-rich meal. J Lipid Res 1988;29:925-936.
11. Heller FR, Vandenplas C, Desager JP, Harvengt C: The vitamin A fat-loading test in young normolipidemic subjects. Clin Chim Acta 1993; 219:167-176.
12. Olefsky JM, Crapo P, Reaven GM: Postprandial plasma triglyceride and cholesterol responses to a low-fat meal. Am J Clin Nutr 1976;29: 535-539.
13. Cohn JS, McNamara JR, Krasinski SD, Russel RM, Schaefer EJ: Role of triglyceride-rich lipoproteins from the liver and intestine in the etiology of postprandial peaks in plasma triglyceride concentration. Metabolism 1989;38:484-490.
14. Fielding BA, Callow J, Owen RM, Samra JS, Matthews DR, Frayn KN: Postprandial lipemia: The origin of an early peak studied by specific dietary fatty acid intake during sequential meals. Am J Clin Nutr 1996;63:36-41.
15. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A: Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest 1993;91:748-758.
16. Conn JS, Johnson EJ, Millar JS, Cohn SD, Milne RW, Marcel YL, Russel RM, Schaefer EJ: Contribution of apo B-48 and apo B-100 triglyceride-rich lipoproteins (TRL) to postprandial increases in the plasma concentration of TRL triglycerides and retinyl esters. J Lipid Res 1993; 34:2033-2040.
17. Havel RJ, Kane JP, Kashyap ML: Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest 1973; 52:32-38.
18. Blum CB: Dynamics of apolipoprotein E metabolism in humans. J Lipid Res 1982;23:1308-1316.
19. Barr SI, Kottke BA, Mao STJ: Postprandial exchange of apolipoprotein C-III between plasma lipoproteins. Am J Clin Nutr 1981;34:191-198.
20. Koga S, Yamanaga Y, Fujii S, Yamamoto K, Ibayashi H: Effects of oral and intravenous fat administration on the levels of apoproteins A-I, A-II and C-III in human subjects. Atherosclerosis 1982;41:115-124.
21. Kashyap ML, Barnhart RL, Srivastava LS, Perisutti G, Allen C, Hogg E, Glueck CJ, Jackson RL: Alimentary lipemia: Plasma high-density lipoproteins and apolipoproteins C-II and C-III in healthy subjects. Am J Clin Nutr 1983;37:233-243.
22. Barr SI, Kottke BA, Mao STJ: Postprandial distribution of apolipoprotein C-II and C-III in normal subjects and patients with mild hypertriglyceridemia: Comparison of meals containing corn oil and medium-chain triglyceride oil. Metabolism 1985;34:983-992.
23. Anuzzi G, Holmquist L, Carlson LA: Concentrations of apolipoproteins B, C-I, C-II, C-III, E and lipids in serum and serum lipoproteins of normal subjects during alimentary lipaemia. Scand J Clin Lab Invest 1989;49:73-81.
24. Groot PHE, Scheck LM: Effects of fat ingestion on high density lipoprotein profiles in human sera. J Lipid Res 1984;25:684-692.
25. Tall AR, Blum CB, Forester GP, Nelson CA: Changes in the distribution and composition of plasma high density lipoproteins after ingestion of fat. J Biol Chem 1982;257:198-207.
26. James RW, Pometta D: Postprandial lipemia differentially influences high density lipoprotein subpopulations LpAI and LpAI, AII. J Lipid Res 1994;35:1583-1591.
27. Green PHR, Glickman RM, Saudeck CD, Blum CB, Tall AR: Human intestinal lipoproteins: Studies in chyluric subjects. J Clin Invest 1979; 64:233-242.
28. Bisgaier CL, Sachdev OP, Megna L, Glickman RM: Distribution of apolipoprotein A-IV in human plasma. J Lipid Res 1985;26:11-25.
29. Seishima M, Noma A, Torizawa H, Muto Y: Changes of apolipoprotein levels after oral administration of fat in human subjects. Atherosclerosis 1988;73:39-43.
30. Zaiou M, Visvikis S, Parra HJ, Steinmetz J, Aguillon D, Jaid M, Fournier B, Boerwinkle E, Siest G: Postprandial effect of an oral fat load on serum apolipoprotein A-IV concentration; in Galteau MM, Siest G, Henny J (eds): Biologie prospective. C R 8e Coll de Pont-à-Mousson. London, Libbey, 1993, pp 545-548.
31. Dalongeville J, Lebel P, Parra HJ, Luc G, Fruchart JC: The postprandial lipaemia is associated with increased levels of apo A-IV in the triglyceride-rich fraction and decreased levels in the denser plasma fractions. Br J Nutr 1997;77:213-223.
32. Karpe F, Bell M, Björkegren J, Hamsten A: Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labelling and simultanenous measurement of apolipoprotein B-48 and B-100. Arterioscler Thromb Vasc Biol 1995;15:199-207.
33. Karpe F, Hamsten A: Determination of apolipoprotein B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res 1994;35:1311-1317.
34. Kotite L, Bergeron N, Havel RJ: Quantification of apolipoproteins B-100, B-48 and E in human triglyceride-rich lipoproteins. J Lipid Res 1995;36:890-900.
35. Weintraub MS, Eisenberg S, Breslow JL: Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III and type IV hyperlipoproteinemic individuals: Effects of treatment with cholestyramine and gemfibrozil. J Clin Invest 1987;79:1110-1119.
36. Sprecher DL, Knauer SL, Black DM, Kaplan LA, Akeson AA, Dusing M, Lattier D, Stein EA, Rymaszewski M, Wiginton DA: Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families. J Clin Invest 1991;88:985-994.
37. Rubinsztein DC, Cohen JC, Berger GM, Van der Westhuyzen DR, Coetzee GA: Chylomicron remnant clearance from the plasma is normal in familial hypercholesterolemic homozygotes with defined receptor defects. J Clin Invest 1990;86:1306-1312.
38. Castro-Cabezas MC, De Bruin TWA, Jansen H, Kock LAW, Kortlandt W, Erkelens DW: Impaired chylomicron remnant clearance in familial combined hyperlipidemia. Arterioscler Thromb 1993;13:804-814.
39. Genest J, Sniderman A, Cianflone K, Teng B, Wacholder S, Marcel Y, Kwiterovith PO Jr: Hyperapobetalipoproteinemia: Plasma lipoprotein responses to oral fat lead. Arteriosclerosis 1986;6:297-304.
40. Miller M, Kwiterovich PO Jr, Bachorik PS, Georgopoulos A: Decreased postprandial response to a fat meal in normotriglyceridemic men with hypoalphalipoproteinemia. Arterioscler Thromb 1993;13: 385-392.
41. Brenninkmeijer BJ, Stuyt PMJ, Demacker PNM, Stalenhoef AFH, Van't Laar A: Catabolism of chylomicron remnants in normolipidemic subjects in relation to the apoprotein E phenotype. J Lipid Res 1987;28:361-370.
42. Weintraub MS, Eisenberg S, Breslow JL: Dietary fact clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J Clin Invest 1987;80:1571-1577.
43. Brown AJ, Roberts DCK: The effect of fasting triacylglyceride concentration and apolipoprotein E on postprandial lipemia. Arterioscler Thromb 1991;11:1737-1744.
44. Boerwinkle E, Brown S, Sharrett AR, Heiss G, Pasch W: Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations. Am J Hum Genet 1994;54:341-360.
45. Bergeron N, Havel RJ: Prolonged postprandial response of lipids and apolipoproteins in triglyceride-rich lipoproteins of individuals expressing an apolipoprotein E4 allele. J Clin Invest 1996;97:65-72.
46. Dart A, Sherrard B, Simpson H: Influence of apo E phenotype on postprandial triglyceride and glucose responses in subjects with and without coronary heart disease. Atherosclerosis 1997;130:161-170.
47. Simons LA, Dwyer T, Simons J, Bernstein L, Mock P, Poonia NS, Balasubramaniam S, Baron D, Branson J, Morgan J, Poy P: Chylomicrons and chylomicron remnants in coronary artery disease: A case-control study. Atherosclerosis 1987; 65:181-189.
48. Simpson HS, Williamson CM, Olivecrona T, Pringle S, Maclean J, Lorimer AR, Bonnefous F, Bogaievsky Y, Packard CJ, Shepherd J: Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis 1990;85:193-202.
49. Groot PHE, Van Stiphout WAHJ, Janse KH, Van Tol A, Van Ramshorst E, Chin-On S, Hofman A, Cresswell SR, Havekes L: Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb 1991;11:653-662.
50. Patsch JR, Miesenböck G, Hopferwieser T, Mühlberger V, Knapp E, Dunn JK, Gotto AM, Patsch W: Relation of triglyceride metabolism and coronary artery disease: Studies in the postprandial state. Arterioscler Thromb 1992;12:1336-1345.
51. Nikkilä M, Solakivi T, Lehtimäki T, Koivula T, Laippala P, Aström B: Postprandial plasma lipoprotein changes in relation to apolipoprotein E phenotypes and low density lipoprotein size in men with and without coronary artery disease. Atherosclerosis 1994;106:149-157.
52. Weintraub MSW, Grosskopf I, Rassin T, Miller H, Charach G, Rotmensch HH, Liron M, Rubinstein A, Iaina A: Clearance of chylomicron remnants in normolipidemic patients with coronary artery disease: Case-control study over three years. BMJ 1996;312:935-939.
53. Phillips NR, Waters D, Havel RJ: Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993;88:2762-2770.
54. Karpe F, Bard JM, Steiner G, Carlson LA, Fruchart JC, Hamsten A: HDLs and alimentary lipemia. Arterioscler Thromb 1993;13:11-22.
55. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A: Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 1994;106:83-97.